Umang Swami

Umang Swami, MD

Huntsman Cancer Institute

Topic Presenter

Biography

Dr. Umang Swami is an Associate Professor of Medicine at Huntsman Cancer Institute, University of Utah, where he serves as Section Leader of the Genitourinary Disease Group and leads the Genitourinary Clinical Trials Research Group. He specializes in genitourinary cancers, with a focus on advancing innovative therapies through clinical and translational research. Dr. Swami earned his medical degree in India, completed his Internal Medicine residency in New York, and pursued Hematology-Oncology fellowship training and a Master of Science in Clinical Investigation at the University of Iowa. He is a Fellow of the American Society of Clinical Oncology (FASCO). He has authored over 180 publications and book chapters, serves on multiple ASCO guideline panels and NCCN Guidelines Panel for Bladder and Penile Cancer. He also serves as Editor-in-Chief of The International Journal of Cancer Care and Delivery (IJCCD), the official journal of Binaytara. An active clinical investigator, Dr. Swami is dedicated to advancing cancer research, improving patient outcomes, and mentoring future generations of oncologists.

Financial Disclosure

Pfizer

Consultant

Gilead

Consultant

Janssen

Consultant

Astellas

Consultant

Exelixis

Consultant

Seattle Genetics

Consultant

ImVax

Consultant

Sanofi

Consultant

AstraZeneca

Consultant

Adaptimmune

Consultant

Flatiron Health

Consultant

Kairos

Consultant

Merck

Consultant

research funding to the institute from AstraZeneca, Astellas/Seattle Genetics, Exelixis, Janssen, Lava Therapeutics, Loxo/Lilly, Merck, Novartis, ORIC Pharmaceuticals and Pfizer

Other